Humalog $35 Copay Card: Lowering Insulin Costs

The Humalog $35 copay card is a game-changer for people living with diabetes. This card reduces the out-of-pocket cost of Humalog insulin to just $35 per prescription.

It's a significant savings for those who rely on this life-saving medication. According to the manufacturer, Eli Lilly and Company, the Humalog $35 copay card can help eligible patients save up to $300 per year.

Eligible patients can use the Humalog $35 copay card to reduce their copay to just $35 per prescription, regardless of their insurance coverage. This can help make Humalog more affordable for those who need it.

Eli Lilly will automatically cap out-of-pocket insulin costs at $35 per month per type of insulin at participating retail pharmacies for people with commercial insurance. This process removes the step of downloading Lilly’s existing $35 copay card for those with commercial insurance.

Approximately 85 percent of U.S. retail pharmacies are participating in this program. You can go to InsulinAffordability.com to immediately download the pharmacy card for those with no health insurance coverage or commercial insurance who use retail pharmacies not participating in the automatic out-of-pocket cap.

There is no limit to the number of vials or pens that can be covered each month as long as they are prescribed, but there is a $16,000 annual coverage limit.

Here are the steps to obtain free insulin through the Lilly Insulin Value Program:

You can also sign up for specific coverage plans that cap out-of-pocket insulin costs at $35 under Medicare.

Eli Lilly announced plans to cap out-of-pocket costs for its most commonly prescribed insulins at $35 per month.

This decision was made in response to the skyrocketing cost of insulin, which has increased by over 1,100 percent over the last two decades.

The company will also set the price of its non-branded insulin, Insulin Lispro Injection 100 units/mL, to $25 a vial.

Additionally, the price of Humalog (insulin lispro injection) 100 units/mL and Humulin (insulin human injection) 100 units/mL will be reduced by 70%.

Lilly will cap insulin prices for patients with and without insurance at $35 per month.

This move is a significant step towards making insulin more affordable for Americans with diabetes.

The company's decision to cap prices at $35 per month is in line with the Inflation Reduction Act, which capped insulin costs at $35 per month for patients with Medicare D.

The Inflation Reduction Act became effective in August 2022, but the provision to cap insulin prices for other patients was struck down prior to its passage.

Eli Lilly's move is expected to make a real difference for Americans with diabetes, according to the company's CEO, David A. Ricks.

Sanofi offers a $35 insulin program, which will be available in Minnesota by the middle of October. This program will make Sanofi's Lantus insulin available for just $35 per month.

Eli Lilly has also made a commitment to cap out-of-pocket insulin costs at $35 per month for both insured and uninsured patients. This includes their most commonly prescribed insulins, such as Humalog.

You can sign up for Sanofi's $35 insulin program on their website, www.lantus.com/sign-up-for-savings. This will give you access to a month's supply of Lantus insulin for just $35.

Eli Lilly's price cap will be implemented for patients with commercial insurance on March 1, 2023, and for those without insurance, they can download a savings card from InsulinAffordability.com to receive Lilly insulins for $35 per month.

The price of Lilly's non-branded insulin, Insulin Lispro Injection 100 units/mL, will be set to $25 a vial, and the price of Humalog and Humulin will be reduced by 70%.

Any Minnesota resident with a valid prescription for an eligible Eli Lilly or Sanofi insulin product can purchase a month-long supply of that product for $35. This program is exclusive to Minnesota residents.

You can purchase Humalog and other Eli Lilly insulin products for $35 a month, but you must choose between using your private insurance or the $35 copay card. If you choose to use the copay card, you would not involve your private insurance in the transaction.

To be eligible, you must have a valid prescription for an Eli Lilly or Sanofi insulin product. The only exception is if you're on a governmental health insurance program like Medical Assistance or Medicare Part D. If you're on Medicare, you can already purchase insulin for $35 thanks to President Biden's American Rescue Plan.

Here are the covered products:

Minnesota residents with a valid prescription for an eligible Eli Lilly or Sanofi insulin product can purchase a month-long supply of that product for $35.

Those on Medicare can already purchase insulin for $35 thanks to President Biden's American Rescue Plan.

Minnesotans on governmental health insurance programs like Medical Assistance or Medicare Part D are not eligible for this program.

If you have private insurance, you must choose whether to use that insurance when buying insulin, or to use this program to buy your prescription for $35 per month.

Individuals with commercial insurance using Lilly insulin will have out-of-pockets capped at $35 per month.

If you're eligible for the $35 insulin program, you'll want to know which products are covered. Eli Lilly's insulin products, including Humalog, Humulin, Insulin Lispro, Basaglar, Lyumjev, and Rezvoglar, are all included.

Sanofi's insulin products, such as Admelog, Lantus, Toujeo, and Apidra, are also covered. This includes any biosimilars of these products that Sanofi markets in the U.S.

Here's a breakdown of the covered products: